Your browser doesn't support javascript.
Whether the timing of patient randomization interferes with the assessment of the efficacy of ruxolitinib for severe COVID-19.
Li, Hailan; Liu, Huaping.
  • Li H; Department of Radiology, Hunan Provincial People's Hospital (The First Affiliate Hospital of Hunan Normal University), Changsha, Hunan, China.
  • Liu H; Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic address: huaziyiranshuai@126.com.
J Allergy Clin Immunol ; 146(6): 1453, 2020 12.
Article in English | MEDLINE | ID: covidwho-802018

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Randomized controlled trials Limits: Humans Language: English Journal: J Allergy Clin Immunol Year: 2020 Document Type: Article Affiliation country: J.jaci.2020.09.002

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Randomized controlled trials Limits: Humans Language: English Journal: J Allergy Clin Immunol Year: 2020 Document Type: Article Affiliation country: J.jaci.2020.09.002